Research on the Evolution, Geometry, and Alterations of the Periorbital Region Based on Age and Deformations
NCT ID: NCT07080320
Last Updated: 2026-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2025-09-16
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dynamic Optical Coherence Tomography(D-OCT) Aging Study: A Preliminary Evaluation of Structural Differences Between Young and Aged Skin, Cellulite and Atrophic Acne Scars in Female Caucasian Subjects With Fitzpatrick Skin Types I-III Utilizing Non-invasive in Vivo D-OCT.
NCT03767400
A Prospective Study of the NUVANCE Facial Rejuvenation System for Mid-Face, Neck and Jowl Rejuvenation Procedures
NCT01100190
Micropore Closure Kinetics at Various Body Sites
NCT03657277
Facial Contouring With Monopolar RF and Continuous Water Cooling
NCT07317089
Clinical and Histological Evaluation of BTL-785F Non-invasive Treatment for Facial Rejuvenation
NCT05987917
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
subjects aged 18-33 years
MoCap
For each subject, the displacement of markers, the deformation of regions between markers, and the evolution of angles formed by the markers during facial expressions and vertical movements will be analyzed with MoCap. These will be compared between the two age groups (18-33 years vs. 50-65 years) using a MANOVA model. The reference values for marker displacement will be defined by the interval between the 2.5% and 97.5% percentiles of the values for each marker. If the distribution is Gaussian, the percentiles will be derived from the standard normal distribution; otherwise, the non-parametric method will be used.
The intervention will be Interventions :
* Recruitment of healthy and pathological subjects.
* Full-face and macro images of the periorbital region
* Measurement of periorbital skin properties using MoCap and standard reference tools.
* Application of a tightening product (aloe vera) and periorbital massage.
* Measurement of skin response to a vertical jump.
subjects aged 50-65 years
MoCap
For each subject, the displacement of markers, the deformation of regions between markers, and the evolution of angles formed by the markers during facial expressions and vertical movements will be analyzed with MoCap. These will be compared between the two age groups (18-33 years vs. 50-65 years) using a MANOVA model. The reference values for marker displacement will be defined by the interval between the 2.5% and 97.5% percentiles of the values for each marker. If the distribution is Gaussian, the percentiles will be derived from the standard normal distribution; otherwise, the non-parametric method will be used.
The intervention will be Interventions :
* Recruitment of healthy and pathological subjects.
* Full-face and macro images of the periorbital region
* Measurement of periorbital skin properties using MoCap and standard reference tools.
* Application of a tightening product (aloe vera) and periorbital massage.
* Measurement of skin response to a vertical jump.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MoCap
For each subject, the displacement of markers, the deformation of regions between markers, and the evolution of angles formed by the markers during facial expressions and vertical movements will be analyzed with MoCap. These will be compared between the two age groups (18-33 years vs. 50-65 years) using a MANOVA model. The reference values for marker displacement will be defined by the interval between the 2.5% and 97.5% percentiles of the values for each marker. If the distribution is Gaussian, the percentiles will be derived from the standard normal distribution; otherwise, the non-parametric method will be used.
The intervention will be Interventions :
* Recruitment of healthy and pathological subjects.
* Full-face and macro images of the periorbital region
* Measurement of periorbital skin properties using MoCap and standard reference tools.
* Application of a tightening product (aloe vera) and periorbital massage.
* Measurement of skin response to a vertical jump.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Caucasian, Fitzpatrick skin types I-III
* BMI between 18.5 and 27, healthy participants
* Aged 18 to 65 years (inclusive)
* Not under guardianship or curatorship
* Informed written consent
* Social security affiliation
* Non-smokers for at least 5 years
* No excessive UV exposure (artificial or natural) in the last 3 weeks prior to the study or during the study
Exclusion Criteria
* Neurovascular history affecting the face
* Ongoing treatments influencing facial tissues (e.g., corticosteroids)
* Current sleep disorders
* Psychiatric conditions or social interaction impairments
* Inner ear or balance disorders
* Osteoporosis, recent fractures, or fragile bone conditions
* Pregnant or breastfeeding women
* Under guardianship, curatorship, or legal protection
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU Amiens
Amiens, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2025_843_0101
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.